Generation of a cell-permeable cycloheptapeptidyl inhibitor against the peptidyl-prolyl isomerase Pin1

被引:15
|
作者
Bedewy, Walaa [1 ]
Liao, Hui [1 ]
Abou-Taleb, Nageh A. [2 ]
Hammad, Sherif F. [2 ]
Nasr, Tamer [2 ]
Pei, Dehua [1 ]
机构
[1] Ohio State Univ, Dept Chem & Biochem, 484 West 12th Ave, Columbus, OH 43210 USA
[2] Helwan Univ, Fac Pharm, Dept Pharmaceut Chem, Helwan, Egypt
基金
美国国家卫生研究院;
关键词
PROTEIN-PROTEIN INTERACTIONS; CANCER-DRIVING PATHWAYS; CYCLIC-PEPTIDES; DISCOVERY; DELIVERY; LIBRARY; DESIGN; GRB2;
D O I
10.1039/c7ob00430c
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
Cyclic peptides are capable of binding and modulating challenging drug targets including protein-protein interactions. However, their lack of membrane permeability prevents their application against intracellular targets. In this study, we show that it is possible to design a cell-permeable and biologically active cycloheptapeptide inhibitor against the intracellular enzyme peptidyl-prolyl isomerase Pin1 by integrating cell-penetrating and target-binding sequences.
引用
收藏
页码:4540 / 4543
页数:4
相关论文
共 50 条
  • [1] A Selective, Cell-Permeable Nonphosphorylated Bicyclic Peptidyl Inhibitor against Peptidyl-Prolyl Isomerase Pin1
    Jiang, Bisheng
    Pei, Dehua
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (15) : 6306 - 6312
  • [2] Roles of peptidyl-prolyl isomerase Pin1 in disease pathogenesis
    Li, Jingyi
    Mo, Chunfen
    Guo, Yifan
    Zhang, Bowen
    Feng, Xiao
    Si, Qiuyue
    Wu, Xiaobo
    Zhao, Zhe
    Gong, Lixin
    He, Dan
    Shao, Jichun
    THERANOSTICS, 2021, 11 (07): : 3348 - 3358
  • [3] Targeting peptidyl-prolyl isomerase PIN1 to inhibit tumor cell aggressiveness
    Beretta, Giovanni L.
    De Cesare, Michelandrea
    Albano, Luisa
    Magnifico, Alessandra
    Carenini, Nives
    Corna, Elisabetta
    Perego, Paola
    Gatti, Laura
    TUMORI, 2016, 102 (02) : 144 - 149
  • [4] Juglone, an inhibitor of the peptidyl-prolyl isomerase Pin1, also directly blocks transcription
    Chao, SH
    Greenleaf, AL
    Price, DH
    NUCLEIC ACIDS RESEARCH, 2001, 29 (03) : 767 - 773
  • [5] An irreversible inhibitor of peptidyl-prolyl cis/trans isomerase Pin1 and evaluation of cytotoxicity
    Ieda, Naoya
    Itoh, Kaoru
    Inoue, Yasumichi
    Izumiya, Yusuke
    Kawaguchi, Mitusyasu
    Miyata, Naoki
    Nakagawa, Hidehiko
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (03) : 353 - 356
  • [6] Peptidyl-prolyl isomerase, Pin1, in acute and chronic liver disease
    Risal, Prabodh
    Jeong, Yeonjun
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 195 - 196
  • [7] Peptidyl-prolyl isomerase, Pin1, in acute and chronic liver disease
    Risal, Prabodh
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 201 - 201
  • [8] Regulation of eukaryotic protein kinases by Pin1, a peptidyl-prolyl isomerase
    Chen, Xiao-Ru
    Igumenova, Tatyana I.
    ADVANCES IN BIOLOGICAL REGULATION, 2023, 87
  • [9] Post-translational Modifications of the Peptidyl-Prolyl Isomerase Pin1
    Chen, Dongmei
    Wang, Long
    Lee, Tae Ho
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [10] Unexpected roles of the peptidyl-prolyl cis/trans isomerase Pin1
    Lavoie, SB
    Albert, AL
    Vincent, M
    M S-MEDECINE SCIENCES, 2003, 19 (12): : 1251 - 1258